Back to Search
Start Over
Dosing and efficacy HIV/AIDS trial using VIMRx Pharmaceuticals' oral hypericin sponsored
- Source :
- AIDS Weekly. Sept 20, 1993, p4, 2 p.
- Publication Year :
- 1993
-
Abstract
- VIMRx Pharmaceuticals Inc. announced that the U.S. National Institutes of Health (NIH) will sponsor oral dose HIV human clinical trials with VIMRxyn, VIMRx's lead hypericin-based antiviral compound. The trials, which [...]
Details
- ISSN :
- 10691456
- Database :
- Gale General OneFile
- Journal :
- AIDS Weekly
- Publication Type :
- News
- Accession number :
- edsgcl.13270693